DK142186A - Fremgangsmaade til fremstilling af polypeptider - Google Patents
Fremgangsmaade til fremstilling af polypeptider Download PDFInfo
- Publication number
- DK142186A DK142186A DK142186A DK142186A DK142186A DK 142186 A DK142186 A DK 142186A DK 142186 A DK142186 A DK 142186A DK 142186 A DK142186 A DK 142186A DK 142186 A DK142186 A DK 142186A
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- superoxide dismutase
- host
- heterologous
- sequence
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract 3
- 108010012715 Superoxide dismutase Proteins 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000233866 Fungi Species 0.000 abstract 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71720985A | 1985-03-28 | 1985-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK142186D0 DK142186D0 (da) | 1986-03-26 |
| DK142186A true DK142186A (da) | 1986-09-29 |
Family
ID=24881138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK142186A DK142186A (da) | 1985-03-28 | 1986-03-26 | Fremgangsmaade til fremstilling af polypeptider |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0196056B1 (de) |
| JP (2) | JPH0829096B2 (de) |
| AT (1) | ATE63757T1 (de) |
| CA (1) | CA1260858A (de) |
| DE (1) | DE3679343D1 (de) |
| DK (1) | DK142186A (de) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0164556B1 (de) * | 1984-05-11 | 1994-03-02 | Chiron Corporation | Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion |
| US6610520B1 (en) | 1985-11-22 | 2003-08-26 | Bio-Technology General Corp. | Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby |
| EP0283244B1 (de) * | 1987-03-16 | 1992-02-12 | Chiron Corporation | Superoxiddismutase-Polymere |
| US5084390A (en) * | 1987-03-16 | 1992-01-28 | Chiron Corporation | Superoxide dismutase polymers |
| EP0284105B1 (de) * | 1987-03-27 | 1995-11-15 | Bio-Technology General Corporation | Menschliches Mangansuperoxiddismutase und Behandlungsverfahren |
| DE3714866A1 (de) * | 1987-05-05 | 1988-11-24 | Hoechst Ag | Verfahren zur herstellung von fremdproteinen in streptomyceten |
| US5683894A (en) * | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
| CA1324969C (en) | 1988-05-06 | 1993-12-07 | Jeffrey R. Shuster | High level expression of proteins in yeast |
| US5858646A (en) * | 1989-02-23 | 1999-01-12 | University Of Ottawa | Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent |
| JPH03151877A (ja) * | 1989-06-02 | 1991-06-28 | Chiron Corp | 骨カルシウム沈着因子 |
| US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| KR920003787B1 (ko) * | 1990-03-05 | 1992-05-14 | 한국과학기술 연구원 | 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법 |
| JPH07108232B2 (ja) * | 1990-10-09 | 1995-11-22 | エム・ディ・リサーチ株式会社 | ペプチド又は蛋白質の製造方法 |
| ATE158816T1 (de) | 1990-11-26 | 1997-10-15 | Genetics Inst | Expression von pace in wirtszellen und verfahren zu dessen verwendung |
| US5736363A (en) * | 1991-07-29 | 1998-04-07 | British Bio-Technology Limited | IGF-II analogues |
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| US5629167A (en) | 1994-04-19 | 1997-05-13 | Biocine S.P.A. | Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| HRP940432B1 (en) * | 1994-08-05 | 2003-10-31 | Pliva Pharm & Chem Works | Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin |
| WO1996020724A1 (en) † | 1994-12-29 | 1996-07-11 | Bio-Technology General Corp. | Generation of human insulin |
| GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
| WO1998016657A1 (en) | 1996-10-17 | 1998-04-23 | Chiron Corporation | Protease regulator screening assay |
| US20050202499A1 (en) | 1996-10-31 | 2005-09-15 | Billing-Medel Patricia A. | Reagents and methods useful for detecting diseases of the breast |
| AU9363798A (en) | 1997-11-06 | 1999-05-31 | Chiron S.P.A. | Neisserial antigens |
| CA2317815A1 (en) | 1998-01-14 | 1999-07-22 | Chiron S.P.A. | Neisseria meningitidis antigens |
| GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| ES2304065T3 (es) | 1998-05-01 | 2008-09-01 | Novartis Vaccines And Diagnostics, Inc. | Antigenos y composiciones de neisseria meningitidis. |
| NZ581940A (en) | 1999-04-30 | 2011-07-29 | Novartis Vaccines & Diagnostic | Conserved neisserial antigens |
| GB9911683D0 (en) | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
| GB9916529D0 (en) | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| RU2281956C2 (ru) | 1999-10-29 | 2006-08-20 | Чирон С.Р.Л. | Антигенные пептиды neisseria |
| DK2289545T3 (en) | 2000-01-17 | 2016-09-05 | Glaxosmithkline Biologicals Sa | Supplemented OMV vaccine against meningococcus |
| AU2001259063A1 (en) | 2000-04-12 | 2001-10-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| EP2189473A3 (de) | 2000-10-27 | 2010-08-11 | Novartis Vaccines and Diagnostics S.r.l. | Nukleinsäure und Proteine von Gruppen A und B Streptokokken |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| US20030072761A1 (en) | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
| JP4413617B2 (ja) | 2001-12-12 | 2010-02-10 | カイロン ソチエタ ア レスポンサビリタ リミタータ | Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓに対する免疫化 |
| EP1463751B1 (de) | 2001-12-21 | 2013-05-22 | Human Genome Sciences, Inc. | Albuminfusionsproteine |
| DK2279746T3 (da) | 2002-11-15 | 2013-11-25 | Novartis Vaccines & Diagnostic | Overfladeproteiner i neisseria meningitidis |
| DE602004014251D1 (de) | 2003-01-31 | 2008-07-17 | Organon Nv | Verfahren zur proteinisolierung unteranoxischen bedingungen |
| GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
| WO2005078077A2 (en) | 2004-02-10 | 2005-08-25 | Zystor Therapeutics, Inc. | Acid alpha-glucosidase and fragments thereof |
| PT2054431E (pt) | 2006-06-09 | 2011-11-03 | Novartis Ag | Confórmeros de adesinas bacterianas |
| US8138318B2 (en) | 2007-09-13 | 2012-03-20 | Abbott Laboratories | Hepatitis B pre-S2 nucleic acid |
| DK2279210T3 (en) | 2008-05-07 | 2017-07-24 | Biomarin Pharm Inc | Lysosomal targeting peptides and uses thereof |
| ES2569514T3 (es) | 2009-06-17 | 2016-05-11 | Biomarin Pharmaceutical Inc. | Formulaciones para enzimas lisosómicas |
| JP6152379B2 (ja) * | 2012-06-29 | 2017-06-21 | 旭化成メディカル株式会社 | プロテインａのｂドメイン変異体を含むポリペプチドが結合された担体からなる吸着材 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
| SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
| DE3486491T2 (de) * | 1983-04-25 | 2003-01-16 | Chiron Corp | Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren |
| GB8314362D0 (en) * | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
| DE3410437A1 (de) * | 1984-03-22 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von proteinen |
-
1986
- 1986-03-25 EP EP86104066A patent/EP0196056B1/de not_active Expired - Lifetime
- 1986-03-25 DE DE8686104066T patent/DE3679343D1/de not_active Expired - Lifetime
- 1986-03-25 AT AT86104066T patent/ATE63757T1/de not_active IP Right Cessation
- 1986-03-25 CA CA000504984A patent/CA1260858A/en not_active Expired
- 1986-03-26 DK DK142186A patent/DK142186A/da not_active Application Discontinuation
- 1986-03-28 JP JP61070648A patent/JPH0829096B2/ja not_active Expired - Lifetime
-
1993
- 1993-03-01 JP JP5040008A patent/JP2545686B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3679343D1 (de) | 1991-06-27 |
| EP0196056A2 (de) | 1986-10-01 |
| EP0196056B1 (de) | 1991-05-22 |
| JPS61268193A (ja) | 1986-11-27 |
| CA1260858A (en) | 1989-09-26 |
| DK142186D0 (da) | 1986-03-26 |
| JP2545686B2 (ja) | 1996-10-23 |
| ATE63757T1 (de) | 1991-06-15 |
| JPH0829096B2 (ja) | 1996-03-27 |
| EP0196056A3 (en) | 1987-12-23 |
| JPH0614793A (ja) | 1994-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK142186A (da) | Fremgangsmaade til fremstilling af polypeptider | |
| CA2168429A1 (en) | Expression of fusion polypeptides transported out of cytoplasm without leader sequences | |
| CA2541651A1 (en) | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | |
| DE68922917D1 (de) | KEX2-Endoprotease und Verfahren zu ihrer Herstellung. | |
| CA2206399A1 (en) | Method for secreting thrombopoietin polypeptides | |
| ATE92959T1 (de) | Herstellung von chimaeren antikoerpern. | |
| HK1012027A1 (en) | A novel cell cycle control protein. | |
| IL87255A0 (en) | Dna constructs containing a kluyveromyces alphafactor leader sequence for directing secretion of heterologous polypeptides | |
| NO973848D0 (no) | Fremgangsmåte til fremstilling av hemoglobinliknende protein | |
| EP0180615A4 (de) | Atrielle natriumuretische/gefässerweiterende polypeptide. | |
| CA2199830A1 (en) | Expression and export technology of proteins as immunofusins | |
| WO1999028462A3 (en) | Polypeptides and nucleic acids encoding the same | |
| EP1027437B8 (de) | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 | |
| DE59611434D1 (de) | Herstellung von Proteinen aus Pro-Proteinen durch Fusionsproteine abgeleitet von Furin oder Furinanalogen | |
| GR861957B (en) | Fusions proteins method for preparing them and their uses | |
| EP1609863A3 (de) | Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure | |
| WO2001051635A3 (en) | Novel stra6 polypeptides | |
| KR910021477A (ko) | 인체 단백질 c의 글리코실화 돌연변이체의 발현을 위한 벡터 및 화합물 | |
| KR970065558A (ko) | 분비형 Kex2 유도체의 제조방법 | |
| KR910018551A (ko) | 스트렙토마이세스에서의 외래 단백질의 제조방법 | |
| SE8601940D0 (sv) | Preparation of fused proteins, antibodies and processes therefor | |
| DK203588D0 (da) | Fremgangsmaade til fremstilling af proteiner | |
| ES2075068T3 (es) | Procedimiento de preparacion de una proteina mediante levaduras que utiliza un sistema inducible, vectores y cepas transformadas correspondientes. | |
| EP0315950A3 (de) | Verfahren zur Züchtung von Zellen, welche rekombinantes Protein exprimieren | |
| EP0750040A3 (de) | Varianten des Makrophagen-stimulierendes-Proteins und Verfahren zur ihrer Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |